1. Effects of the introduction of new vaccines in Guinea-Bissau on vaccine coverage, vaccine timeliness, and child survival: an observational study 
Dr Ane B Fisker, PhD, Linda Hornshøj, MD, Amabelia Rodrigues, PhD, Ibraima Balde, BSc, Manuel Fernandes, Prof Christine S Benn, DMSc, Prof Peter Aaby, DMSc 
The Lancet Global Health 
Volume 2, Issue 8, Pages e478-e487 (August 2014)
DOI: /S X(14)
Copyright © 2014 Fisker et al. Open Access article distributed under the terms of CC BY Terms and Conditions

2. Figure 1 Description of the 2007 and 2009 cohorts
*Children living in villages where a research project provided all health interventions.
The Lancet Global Health 2014 2, e478-e487DOI: ( /S X(14) )
Copyright © 2014 Fisker et al. Open Access article distributed under the terms of CC BY Terms and Conditions

3. Figure 2 Description of the 1999–2006 cohort.
The Lancet Global Health 2014 2, e478-e487DOI: ( /S X(14) )
Copyright © 2014 Fisker et al. Open Access article distributed under the terms of CC BY Terms and Conditions

4. Figure 3 Mortality of children according to measles vaccination status
Includes children who received measles vaccine after 12 months of age; children contributed an observation time after card inspection (at which they were classified as vaccinated or unvaccinated) and stayed in the analysis for the next 6 months.
The Lancet Global Health 2014 2, e478-e487DOI: ( /S X(14) )
Copyright © 2014 Fisker et al. Open Access article distributed under the terms of CC BY Terms and Conditions